Stock comparison
AMGEN INC is 13.7x more valuable than EXELIXIS, INC. by market capitalization ($196.25 B vs $14.35 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
AMGN is larger
AMGEN INC is 13.7x more valuable than EXELIXIS, INC. by market capitalization ($196.25 B vs $14.35 B).
Market value leader
AMGN
AMGEN INC is 13.7x more valuable than EXELIXIS, INC. by market capitalization ($196.25 B vs $14.35 B).
Revenue leader
AMGN
EXEL: $2.32B vs AMGN: $36.75B.
Profit leader
AMGN
EXEL: $782.60M vs AMGN: $7.71B.
Margin leader
EXEL
EXEL: 33.7% vs AMGN: 21.0% net margin.
| Metric | EXEL | AMGN |
|---|---|---|
| Market cap | $14.35 B | $196.25 B |
| US-listed rank | #763 | #77 |
| Revenue (latest FY) | $2.32B | $36.75B |
| Net income (latest FY) | $782.60M | $7.71B |
| Net margin | 33.7% | 21.0% |
| P/E (trailing FY) | 18.3x | 25.5x |
| SEC filings | 2,488 | 1,011 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
AMGEN INC is 13.7x more valuable than EXELIXIS, INC. by market capitalization ($196.25 B vs $14.35 B).
In their latest fiscal years, EXELIXIS, INC. reported $2.32B in revenue while AMGEN INC reported $36.75B.
Full pages: EXELIXIS, INC. and AMGEN INC, or browse the full rankings.